{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:24:16Z","timestamp":1783351456991,"version":"3.54.6"},"reference-count":24,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Placenta accreta spectrum (PAS) and placenta previa (PP) are severe obstetric disorders associated with high maternal and perinatal morbidity. Early diagnosis of both conditions remains challenging, particularly in cases with subtle imaging findings. This study was aimed to evaluate the diagnostic value of first-trimester maternal serum levels of pregnancy-associated plasma protein-A (PAPP-A) and free beta subunit of human chorionic gonadotropin (\u03b2-hCG) in predicting PAS and PP. In this retrospective case\u2013control study, a total of 100 pregnant women were included: 36 with PAS, 32 with PP, and 32 healthy controls. Serum levels were measured at 11\u2013136 weeks of gestation. Both biomarkers were significantly altered in pathological groups compared to controls: PAPP-A was lower in PP (3.04 [1.42\u20134.52] IU\/L) and PAS (3.63 [2.51\u20135.39] IU\/L) vs. controls (5.34 [3.72\u20138.41] IU\/L; p &lt; 0.001), while \u03b2-hCG was higher in PP (45.4 [40.1\u201354.9] IU\/L) and PAS (51.4 [32.3\u201374.8] IU\/L) vs. controls (33.5 [22.7\u201354.1] IU\/L; p = 0.044 and p &lt; 0.001, respectively). ROC analysis demonstrated that combined biomarker modeling improved diagnostic accuracy over single-marker use, with AUCs reaching 0.85 (sensitivity 85.2%, specificity 72%) for PAS and 0.88 (sensitivity 100%, specificity 72%) for PP. These findings support the integration of biochemical screening into first-trimester risk assessment protocols. Incorporating maternal serum biomarkers may enhance early identification of high-risk pregnancies, allow timely referral to specialized care, and reduce adverse outcomes. Further prospective studies are warranted to validate the utility of this dual-marker approach across diverse populations and clinical settings.<\/jats:p>","DOI":"10.3390\/ijms26136187","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T03:33:25Z","timestamp":1750995205000},"page":"6187","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Combined First-Trimester PAPP-A and Free \u03b2-hCG Levels for the Early Diagnosis of Placenta Accreta Spectrum and Placenta Previa: A Case-Control Study"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8332-7073","authenticated-orcid":false,"given":"Vera","family":"Belousova","sequence":"first","affiliation":[{"name":"I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Ignatko","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Bogomazova","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4693-6886","authenticated-orcid":false,"given":"Evdokiya","family":"Zarova","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1339-5422","authenticated-orcid":false,"given":"Svetlana","family":"Pesegova","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Samusevich","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madina","family":"Kardanova","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8664-3536","authenticated-orcid":false,"given":"Oxana","family":"Skorobogatova","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Kuzmina","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3467-886X","authenticated-orcid":false,"given":"Natalia","family":"Kireeva","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0912-6796","authenticated-orcid":false,"given":"Anna","family":"Maltseva","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2147\/IJWH.S224191","article-title":"Placenta Accreta Spectrum Disorders: Challenges, Risks, and Management Strategies","volume":"12","author":"Morlando","year":"2020","journal-title":"Int. J. Women\u2019s Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tjog.2017.04.016","article-title":"Maternal Outcome after Conservative Management of Abnormally Invasive Placenta","volume":"56","author":"Su","year":"2017","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/aogs.12081","article-title":"Prenatal Diagnosis of Abnormally Invasive Placenta Reduces Maternal Peripartum Hemorrhage and Morbidity","volume":"92","author":"Chantraine","year":"2013","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_4","first-page":"5","article-title":"Placenta Accreta: A Modern View on Etiopathogenesis and Obstetric Tactics","volume":"1","author":"Ignatko","year":"2024","journal-title":"Akusherstvo I Ginekol. Obstet. Gynecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ijgo.12761","article-title":"FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO Classification for the Clinical Diagnosis of Placenta Accreta Spectrum Disorders","volume":"146","author":"Jauniaux","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ijgo.12407","article-title":"FIGO Consensus Guidelines on Placenta Accreta Spectrum Disorders: Epidemiology","volume":"140","author":"Jauniaux","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/uog.19045","article-title":"Diagnostic Accuracy of First-Trimester Ultrasound in Detecting Abnormally Invasive Placenta in High-Risk Women with Placenta Previa","volume":"52","author":"Cali","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/uog.20104","article-title":"Screening for Morbidly Adherent Placenta in Early Pregnancy","volume":"53","author":"Panaiotova","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/aogs.13258","article-title":"Diagnostic Accuracy of Magnetic Resonance Imaging in Detecting the Severity of Abnormal Invasive Placenta: A Systematic Review and Meta-Analysis. Acta Obstet","volume":"97","author":"Familiari","year":"2018","journal-title":"Gynecol. Scand."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00247-019-04521-2","article-title":"Placental Magnetic Resonance Imaging Part II: Placenta Accreta Spectrum","volume":"50","author":"Brown","year":"2020","journal-title":"Pediatr. Radiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2013.05.009","article-title":"Human Chorionic Gonadotropin and Its Free \u03b2-Subunit Stimulate Trophoblast Invasion Independent of LH\/hCG Receptor","volume":"375","author":"Lee","year":"2013","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/1471-0528.13298","article-title":"First Trimester Maternal Serum Biochemical Markers of Aneuploidy in Pregnancies with Abnormally Invasive Placentation","volume":"122","author":"Thompson","year":"2015","journal-title":"BJOG"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1507674","DOI":"10.1155\/2018\/1507674","article-title":"Placenta Accreta Spectrum: A Review of Pathology, Molecular Biology, and Biomarkers","volume":"2018","author":"Bartels","year":"2018","journal-title":"Dis. Markers"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Zhang, T., and Wang, S. (2022). Potential Serum Biomarkers in Prenatal Diagnosis of Placenta Accreta Spectrum. Front. Med., 9.","DOI":"10.3389\/fmed.2022.860186"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Swiercz, G., Zmelonek-Znamirowska, A., Szwabowicz, K., Armanska, J., Detka, K., Mlodawska, M., and Mlodawski, J. (2024). Evaluating the Predictive Efficacy of First Trimester Biochemical Markers (PAPP-A, f\u03b2-hCG) in Forecasting Preterm Delivery Incidences. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-67300-6"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Swiercz, G., Zmelonek-Znamirowska, A., Szwabowicz, K., Armanska, J., Detka, K., Mlodawska, M., and Mlodawski, J. (2024). Navigating Uncertain Waters: First-Trimester Screening\u2019s Role in Identifying Neonatal Complications. J. Clin. Med., 13.","DOI":"10.3390\/jcm13071982"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/pd.2858","article-title":"PAPP-A and Free \u03b2-hCG in Relation to Admission to Neonatal Intensive Care Unit and Neonatal Disease","volume":"31","author":"Kirkegaard","year":"2011","journal-title":"Prenat. Diagn."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/uog.26299","article-title":"Urological Complications in Women Undergoing Cesarean Section for Placenta Accreta Spectrum Disorders: Systematic Review and Meta-Analysis","volume":"62","author":"Lucidi","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"193.e1","DOI":"10.1016\/j.ajog.2018.04.049","article-title":"Placenta Percreta Is Associated with More Frequent Severe Maternal Morbidity Than Placenta Accreta","volume":"219","author":"Marcellin","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/uog.13194","article-title":"Prenatal Identification of Invasive Placentation Using Ultrasound: Systematic Review and Meta-Analysis","volume":"42","author":"Iacovella","year":"2013","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/uog.3881","article-title":"Screening for Pre-Eclampsia and Fetal Growth Restriction by Uterine Artery Doppler and PAPP-A at 11\u201314 Weeks\u2019 Gestation","volume":"29","author":"Pilalis","year":"2007","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1515\/jpm-2019-0261","article-title":"Significance of the Routine First-Trimester Antenatal Screening Program for Aneuploidy in the Assessment of the Risk of Placenta Accreta Spectrum Disorders","volume":"48","author":"Penzhoyan","year":"2019","journal-title":"J. Perinat. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/14767058.2016.1275546","article-title":"Relationship between First Trimester Aneuploidy Screening Test Serum Analytes and Placenta Accreta","volume":"31","author":"Akkaya","year":"2018","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e34473","DOI":"10.1097\/MD.0000000000034473","article-title":"Meta-Analysis for the Relationship between Circulating Pregnancy-Associated Plasma Protein A and Placenta Accreta Spectrum","volume":"102","author":"Li","year":"2023","journal-title":"Medicine"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/13\/6187\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:59:43Z","timestamp":1760032783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/13\/6187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":24,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["ijms26136187"],"URL":"https:\/\/doi.org\/10.3390\/ijms26136187","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}